122 related articles for article (PubMed ID: 35074409)
1. The proteomic landscape of ovarian cancer cells in response to melatonin.
Cesário RC; Gaiotte LB; Cucielo MS; Silveira HS; Delazari Dos Santos L; de Campos Zuccari DAP; Seiva FRF; Reiter RJ; de Almeida Chuffa LG
Life Sci; 2022 Apr; 294():120352. PubMed ID: 35074409
[TBL] [Abstract][Full Text] [Related]
2. Melatonin Reverses the Warburg-Type Metabolism and Reduces Mitochondrial Membrane Potential of Ovarian Cancer Cells Independent of MT1 Receptor Activation.
Cucielo MS; Cesário RC; Silveira HS; Gaiotte LB; Dos Santos SAA; de Campos Zuccari DAP; Seiva FRF; Reiter RJ; de Almeida Chuffa LG
Molecules; 2022 Jul; 27(14):. PubMed ID: 35889222
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-545 suppresses progression of ovarian cancer through mediating PLK1 expression by a direct binding and an indirect regulation involving KDM4B-mediated demethylation.
Zhang H; Zhang K; Xu Z; Chen Z; Wang Q; Wang C; Cui J
BMC Cancer; 2021 Feb; 21(1):163. PubMed ID: 33588776
[TBL] [Abstract][Full Text] [Related]
4. MIEF2 over-expression promotes tumor growth and metastasis through reprogramming of glucose metabolism in ovarian cancer.
Zhao S; Zhang X; Shi Y; Cheng L; Song T; Wu B; Li J; Yang H
J Exp Clin Cancer Res; 2020 Dec; 39(1):286. PubMed ID: 33317572
[TBL] [Abstract][Full Text] [Related]
5. HOTAIR promotes paclitaxel resistance by regulating CHEK1 in ovarian cancer.
Jiang J; Wang S; Wang Z; Cai J; Han L; Xie L; Han Q; Wang W; Zhang Y; He X; Yang C
Cancer Chemother Pharmacol; 2020 Aug; 86(2):295-305. PubMed ID: 32743678
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of bromodomain PHD finger transcription factor in ovarian cancer and its critical role for cancer cell proliferation and survival.
Miao J; Zhang M; Huang X; Xu L; Tang R; Wang H; Han S
Biochem Cell Biol; 2021 Jun; 99(3):304-312. PubMed ID: 32985220
[TBL] [Abstract][Full Text] [Related]
7. Apoptosis is triggered by melatonin in an in vivo model of ovarian carcinoma.
Chuffa LG; Alves MS; Martinez M; Camargo IC; Pinheiro PF; Domeniconi RF; Júnior LA; Martinez FE
Endocr Relat Cancer; 2016 Feb; 23(2):65-76. PubMed ID: 26555801
[TBL] [Abstract][Full Text] [Related]
8. miR-450a Acts as a Tumor Suppressor in Ovarian Cancer by Regulating Energy Metabolism.
Muys BR; Sousa JF; Plaça JR; de Araújo LF; Sarshad AA; Anastasakis DG; Wang X; Li XL; de Molfetta GA; Ramão A; Lal A; Vidal DO; Hafner M; Silva WA
Cancer Res; 2019 Jul; 79(13):3294-3305. PubMed ID: 31101765
[TBL] [Abstract][Full Text] [Related]
9. NCALD affects drug resistance and prognosis by acting as a ceRNA of CX3CL1 in ovarian cancer.
Dong C; Yin F; Zhu D; Cai X; Chen C; Liu X
J Cell Biochem; 2020 Nov; 121(11):4470-4483. PubMed ID: 32030795
[TBL] [Abstract][Full Text] [Related]
10. Melatonin as a promising agent to treat ovarian cancer: molecular mechanisms.
Chuffa LGA; Reiter RJ; Lupi LA
Carcinogenesis; 2017 Oct; 38(10):945-952. PubMed ID: 28575150
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of MicroRNA-375 Promoter Methylation in Promoting Ovarian Cancer Cell Malignancy.
Shu J; Xiao L; Yan S; Fan B; Zou X; Yang J
Technol Cancer Res Treat; 2021; 20():1533033820980115. PubMed ID: 33928819
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of NDRG2 promotes the therapeutic effect of pazopanib on ovarian cancer.
Cui Y; Shen G; Ma L; Lv Q
J Recept Signal Transduct Res; 2021 Dec; 41(6):546-552. PubMed ID: 33050824
[TBL] [Abstract][Full Text] [Related]
13. Novel role of lncRNA CHRF in cisplatin resistance of ovarian cancer is mediated by miR-10b induced EMT and STAT3 signaling.
Tan WX; Sun G; Shangguan MY; Gui Z; Bao Y; Li YF; Jia ZH
Sci Rep; 2020 Sep; 10(1):14768. PubMed ID: 32901049
[TBL] [Abstract][Full Text] [Related]
14. Melatonin Reduces Angiogenesis in Serous Papillary Ovarian Carcinoma of Ethanol-Preferring Rats.
Zonta YR; Martinez M; Camargo IC; Domeniconi RF; Lupi Júnior LA; Pinheiro PF; Reiter RJ; Martinez FE; Chuffa LG
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28398226
[TBL] [Abstract][Full Text] [Related]
15. Increased WD-repeat containing protein 1 in interstitial fluid from ovarian carcinomas shown by comparative proteomic analysis of malignant and healthy gynecological tissue.
Haslene-Hox H; Oveland E; Woie K; Salvesen HB; Wiig H; Tenstad O
Biochim Biophys Acta; 2013 Nov; 1834(11):2347-59. PubMed ID: 23707566
[TBL] [Abstract][Full Text] [Related]
16. Melatonin restrains angiogenic factors in triple-negative breast cancer by targeting miR-152-3p: In vivo and in vitro studies.
Marques JHM; Mota AL; Oliveira JG; Lacerda JZ; Stefani JP; Ferreira LC; Castro TB; Aristizábal-Pachón AF; Zuccari DAPC
Life Sci; 2018 Sep; 208():131-138. PubMed ID: 29990486
[TBL] [Abstract][Full Text] [Related]
17. Quantitative Proteomic Profiling Reveals That Diverse Metabolic Pathways Are Influenced by Melatonin in an in Vivo Model of Ovarian Carcinoma.
Chuffa LG; Lupi Júnior LA; Seiva FR; Martinez M; Domeniconi RF; Pinheiro PF; Dos Santos LD; Martinez FE
J Proteome Res; 2016 Oct; 15(10):3872-3882. PubMed ID: 27604906
[TBL] [Abstract][Full Text] [Related]
18. The role of nucleolar spindle-associated protein 1 in human ovarian cancer.
Zhang Y; Huang K; Cai H; Chen S; Sun D; Jiang P
J Cell Biochem; 2020 Nov; 121(11):4397-4405. PubMed ID: 32031285
[TBL] [Abstract][Full Text] [Related]
19. Melatonin is a potential inhibitor of ovarian cancer: molecular aspects.
Zare H; Shafabakhsh R; Reiter RJ; Asemi Z
J Ovarian Res; 2019 Mar; 12(1):26. PubMed ID: 30914056
[TBL] [Abstract][Full Text] [Related]
20. Identification of novel candidate biomarkers of epithelial ovarian cancer by profiling the secretomes of three-dimensional genetic models of ovarian carcinogenesis.
Lawrenson K; Mhawech-Fauceglia P; Worthington J; Spindler TJ; O'Brien D; Lee JM; Spain G; Sharifian M; Wang G; Darcy KM; Pejovic T; Sowter H; Timms JF; Gayther SA
Int J Cancer; 2015 Oct; 137(8):1806-17. PubMed ID: 25204737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
